Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis

Zexing Wang,Meiqi Wang,Fei Yang,Weiwei Nie,Fengxia Chen,Jing Xu,Xiaoxiang Guan

Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis

2014

Zexing Wang
Meiqi Wang
Fei Yang
Weiwei Nie
Fengxia Chen
Jing Xu
Xiaoxiang Guan

Purpose We undertook a meta-analysis of randomized trials to evaluate the efficacy of multitargeted antiangiogenic tyrosine kinase inhibitors (MATKIs) in addition to chemotherapy in metastatic breast cancer.

Keywords:

Anesthesia
Medicine
Cancer research
Tyrosine kinase
Pharmacology
Chemotherapy
Metastatic breast cancer
Oncology
Randomized controlled trial
pharmacology toxicology
Diabetes mellitus
Meta-analysis
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations